Vericel is committed to improving the lives of patients with serious conditions by developing and manufacturing innovative cell therapies and specialty biologics.
Vericel is passionately committed to meeting significant patient and healthcare provider needs by providing potentially life-enhancing cell therapies to patients with serious medical conditions.
Vericel believes in encouraging each employee to exceed the expectations of the patients we serve, their healthcare providers, and the shareholders who support our efforts.
Additional Company Representatives
Jon Hopper, BSc, MB ChB, FRCSEd, DIMC RCSEd, MBA
Chief Medical Officer
Roland P. DeAngelis, Jr.
Senior Vice President, Commercial Operations
Executive Cell Therapy Specialist
Shelley E. Brown, PhD, MDiv
Medical Science Liaison
No results found